N-((S)-2-((S)-3-Hydroxypyrrolidin-1-yl)-1-phenylethyl)-N-methyl-2,2-diphenylacetamide
| Title | Journal |
|---|---|
| Asimadoline and its potential for the treatment of diarrhea-predominant irritable bowel syndrome: a review. | Clinical and experimental gastroenterology 20120101 |
| Drug management of visceral pain: concepts from basic research. | Pain research and treatment 20120101 |
| The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain. | European journal of pharmacology 20111205 |
| Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome. | Gut and liver 20110901 |
| SA14867, a newly synthesized kappa-opioid receptor agonist with antinociceptive and antipruritic effects. | European journal of pharmacology 20101125 |
| Asimadoline in the treatment of irritable bowel syndrome. | Expert opinion on investigational drugs 20101001 |
| Involvement of kappa-opioid receptors in visceral nociception in mice. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20081001 |
| Novel pharmacology: asimadoline, a kappa-opioid agonist, and visceral sensation. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20080901 |
| Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. | Alimentary pharmacology & therapeutics 20080701 |
| Asimadoline, a kappa-opioid agonist, and satiation in functional dyspepsia. | Alimentary pharmacology & therapeutics 20080601 |
| Opioid-induced bowel dysfunction. | Current treatment options in gastroenterology 20080201 |
| Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat. | European journal of pharmacology 20071114 |
| Efficacy of on-demand asimadoline, a peripheral kappa-opioid agonist, in females with irritable bowel syndrome. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20071101 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20071101 |
| Ligands regulate cell surface level of the human kappa opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists. | The Journal of pharmacology and experimental therapeutics 20061101 |
| Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats. | Diabetologia 20061101 |
| Peripheral opioids for functional GI disease: a reappraisal. | Digestive diseases (Basel, Switzerland) 20060101 |
| Endogenous opioid analgesia in peripheral tissues and the clinical implications for pain control. | Therapeutics and clinical risk management 20051201 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20041101 |
| The kappa-opioid receptor agonist asimadoline inhibits epithelial transport in mouse trachea and colon. | European journal of pharmacology 20041025 |
| Functional dyspepsia: drugs for new (and old) therapeutic targets. | Best practice & research. Clinical gastroenterology 20040801 |
| Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome. | Alimentary pharmacology & therapeutics 20040715 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20040301 |
| Arylacetamide kappa-opioid receptor agonists produce a tonic- and use-dependent block of tetrodotoxin-sensitive and -resistant sodium currents in colon sensory neurons. | The Journal of pharmacology and experimental therapeutics 20031001 |
| Effects of asimadoline, a kappa-opioid agonist, on satiation and postprandial symptoms in health. | Alimentary pharmacology & therapeutics 20030901 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20030601 |
| Effects of a kappa-opioid agonist, asimadoline, on satiation and GI motor and sensory functions in humans. | American journal of physiology. Gastrointestinal and liver physiology 20030401 |
| Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20030101 |
| CJ-15,208, a novel kappa opioid receptor antagonist from a fungus, Ctenomyces serratus ATCC15502. | The Journal of antibiotics 20021001 |
| The kappa-opioid agonist, asimadoline, alters cytokine gene expression in adjuvant arthritis. | Rheumatology (Oxford, England) 20010901 |